Cargando…
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors
Human dihydroorotate dehydrogenase (hDHODH) is a class-2 dihydroorotate dehydrogenase. Because it is extensively used by proliferating cells, its inhibition in autoimmune and inflammatory diseases, cancers, and multiple sclerosis is of substantial clinical importance. In this study, we had two aims....
Autores principales: | Shih, Kuei-Chung, Lee, Chi-Ching, Tsai, Chi-Neu, Lin, Yu-Shan, Tang, Chuan-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913663/ https://www.ncbi.nlm.nih.gov/pubmed/24504131 http://dx.doi.org/10.1371/journal.pone.0087960 |
Ejemplares similares
-
The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis
por: Sibille, Giulia, et al.
Publicado: (2022) -
Babesia bovis Dihydroorotate Dehydrogenase
(BboDHODH) is a Novel Molecular Target of Drug for Bovine Babesiosis
por: KAMYINGKIRD, Ketsarin, et al.
Publicado: (2013) -
Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology
por: Ladds, Marcus J. G.W., et al.
Publicado: (2021) -
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
por: Kaur, Hardeep, et al.
Publicado: (2021) -
Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate
Dehydrogenase
(DHODH)
por: Lucas-Hourani, Marianne, et al.
Publicado: (2015)